Clinical trial

This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091

NCT03780725

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention BI 754111 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention [89Zr]Zr-BI 754111 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention BI 754091 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2019-01-22

PhasePHASE1

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Head and Neck Neoplasmsunresolved

Interventions

BI 754111DRUG

[89Zr]Zr-BI 754111DRUG

BI 754091DRUG

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Mapped research locations

AmsterdamNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03780725 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.